n-methyl-3,4-methylenedioxyamphetamine has been researched along with Amnesia-Memory Loss in 6 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Excerpt | Relevance | Reference |
---|---|---|
"The present study was designed to investigate possible involvement of the central amygdala (CeA) nicotinic acetylcholine (nACh) and 5-hydroxytryptamine 1A (5-HT1A) receptors in the reversal effect of nicotine and 3,4-methylenedioxy-N-methylamphetamine (MDMA or ecstasy) on morphine-induced amnesia." | 7.80 | Central amygdala nicotinic and 5-HT1A receptors mediate the reversal effect of nicotine and MDMA on morphine-induced amnesia. ( Rezayof, A; Tirgar, F; Zarrindast, MR, 2014) |
"The present study was designed to investigate possible involvement of the central amygdala (CeA) nicotinic acetylcholine (nACh) and 5-hydroxytryptamine 1A (5-HT1A) receptors in the reversal effect of nicotine and 3,4-methylenedioxy-N-methylamphetamine (MDMA or ecstasy) on morphine-induced amnesia." | 3.80 | Central amygdala nicotinic and 5-HT1A receptors mediate the reversal effect of nicotine and MDMA on morphine-induced amnesia. ( Rezayof, A; Tirgar, F; Zarrindast, MR, 2014) |
"A 26-year-old woman suffered disseminated intravascular coagulation (DIC) and a brief respiratory arrest following recreational use of 3,4-methylene-dioxymethamphetamine (MDMA; 'ecstasy'), together with amyl nitrate, lysergic acid (LSD), cannabis and alcohol." | 1.31 | Amnesic syndrome and severe ataxia following the recreational use of 3,4-methylene-dioxymethamphetamine (MDMA, 'ecstasy') and other substances. ( Isaac, C; Jaldow, E; Kopelman, MD; Laing, H; Marsden, P; Mayes, AR; Reed, LJ, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Pantoni, MM | 1 |
Kim, JL | 1 |
Van Alstyne, KR | 1 |
Anagnostaras, SG | 1 |
Tirgar, F | 1 |
Rezayof, A | 1 |
Zarrindast, MR | 1 |
Brüggemann, N | 1 |
Heldmann, M | 1 |
Sprenger, A | 1 |
Repenthin, J | 1 |
Münte, TF | 1 |
Fischer, RB | 1 |
Spatt, J | 1 |
Glawar, B | 1 |
Mamoli, B | 1 |
Kopelman, MD | 1 |
Reed, LJ | 1 |
Marsden, P | 1 |
Mayes, AR | 1 |
Jaldow, E | 1 |
Laing, H | 1 |
Isaac, C | 1 |
1 review available for n-methyl-3,4-methylenedioxyamphetamine and Amnesia-Memory Loss
Article | Year |
---|---|
MDMA and memory, addiction, and depression: dose-effect analysis.
Topics: Amnesia; Animals; Conditioning, Classical; Depression; Dose-Response Relationship, Drug; Fear; Mice; | 2022 |
5 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Amnesia-Memory Loss
Article | Year |
---|---|
Central amygdala nicotinic and 5-HT1A receptors mediate the reversal effect of nicotine and MDMA on morphine-induced amnesia.
Topics: Amnesia; Animals; Central Amygdaloid Nucleus; Dose-Response Relationship, Drug; Male; Mecamylamine; | 2014 |
Acute amnestic syndrome due to MDMA exposure.
Topics: Amnesia; Brain; Hallucinogens; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamine; | 2016 |
[Psychiatric illness associated with amphetamines and other stimulants].
Topics: Adult; Amnesia; Amphetamines; Central Nervous System Stimulants; Cognition Disorders; Designer Drugs | 2000 |
A pure amnestic syndrome after MDMA ("ecstasy") ingestion.
Topics: Administration, Oral; Adult; Amnesia; Female; Globus Pallidus; Hallucinogens; Humans; Magnetic Reson | 1997 |
Amnesic syndrome and severe ataxia following the recreational use of 3,4-methylene-dioxymethamphetamine (MDMA, 'ecstasy') and other substances.
Topics: Adult; Amnesia; Brain Mapping; Cerebellar Ataxia; Disseminated Intravascular Coagulation; Drug Inter | 2001 |